Delaying the Onset of Nearsightedness Until Treatment Study

• Status: Withdrawn
• Trial end date: 2024-08-31
• Target enrollment: 0
• Participant gender: All

Summary

Participants eligible for the study will be randomized to one of three concentrations of atropine and followed for a month.

• Phase: Phase 1
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Ohio State University
• Collaborators: Case Western Reserve University; Illinois College of Optometry; Indiana University; New England College of Optometry; Pennsylvania College of Optometry; Southern California College of Optometry at Marshall B. Ketchum University; Southern College of Optometry; Stanford University; State University of New York; University of California, Berkeley; University of Houston; University of Missouri, St. Louis; University of the Incarnate Word
• Treatments: Atropine

Criteria

Inclusion Criteria:

• Age: 6-11 years

• Refractive error measured in spherical equivalent, one eye meets criterion

• 6 years old: 0.50 to +0.38

• 7 years old: 0.50 to +0.25

• 8-11 years old: 0.50 to plano

• Anisometropia: spherical equivalent <1.50 D

• Astigmatism: <1.50 in both eyes

• Myopia: Less myopic than -0.74 D, both eyes

Exclusion Criteria:

● Myopic